Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-let-7e: Hsa-let-7e (MIMAT0000066) is one of the primers used in the study [PMC3821025]. The study found that DIM, a compound, can inhibit the expression of EZH2 in castration-resistant prostate cancer [PMC6222788]. This inhibition is achieved by up-regulating hsa-let-7e, which is ranked at 13th among the primers used [PMC6222788]. The up-regulation of hsa-let-7e by DIM leads to a decrease in EZH2 expression [PMC6222788]. This finding suggests that hsa-let-7e may play a role in regulating EZH2 expression in castration-resistant prostate cancer [PMC6222788]. Further research is needed to fully understand the mechanism by which hsa-let-7e regulates EZH2 and its potential therapeutic implications for castration-resistant prostate cancer [PMC6222788].
mRNA interactions
6 total
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset